High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: Results of a cross-sectional epidemiological survey in Gran Canaria, Spain

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Boronat, Mauro ^a,b   Saavedra, Pedro ^b   Pérez Martín, Nuria ^a   López Madrazo, María J ^a   Rodríguez Pérez, Carlos ^a   Nóvoa, Francisco J ^a,b  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Age; Diabetes; HOMA IR; Insulin resistance; Lipoprotein(a)

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PATIENT IDENTIFICATION; POPULATION RESEARCH; PREVALENCE; PROBABILITY; RISK FACTOR; SPAIN; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGING; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEIN(A); LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SPAIN; UP-REGULATION;

EID: 84863100136     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-81     Document Type: Article

References (23)

1. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen M-R, Tokgözoglu L, Tybjærg-Hansen A, . for the European Atherosclerosis Society Consensus Panel Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010, 31:2844-2853. 10.1093/eurheartj/ehq386, 3295201, 20965889, for the European Atherosclerosis Society Consensus Panel.
2. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90 % of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992, 90:52-60. 10.1172/JCI115855, 443062, 1386087.
3. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009, 301:2331-2339. 10.1001/jama.2009.801, 19509380.
4. Li C, Ford ES, Tsai J, Zhao G, Balluz LS, Gidding SS. Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study. Cardiovasc Diabetol 2011, 10:46-57. 10.1186/1475-2840-10-46, 3127754, 21605423.
5. Herder C, Karakas M, Koenig W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 2011, 90:52-66. 10.1038/clpt.2011.93, 21654741.
6. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2011, 10:103-110. 10.1186/1475-2840-10-103, 3235986, 22108456.
7. Jenkins AJ, Steele JS, Janus ED, Santamaria JD, Best JD. Plasma apolipoprotein (a) is increased in Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1992, 35:1055-1059. 10.1007/BF02221681, 1473615.
8. Habib SS, Aslam M, Shah SFA, Naveed AK. Lipoprotein (a) is associated with basal insulin levels in patients with type 2 diabetes mellitus. Arq Bras Cardiol 2009, 93:25-30.
9. Haffner SM, Morales PA, Stern MP, Gruber KK. Lp(a) concentrations in NIDDM. Diabetes 1992, 41:1267-1272. 10.2337/diabetes.41.10.1267, 1397699.
10. Rainwater DL, MacCluer JW, Stern MP, VandeBerg JL, Haffner SM. Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes 1994, 43:942-946. 10.2337/diabetes.43.7.942, 8013760.
11. Mora S, Kamstrup PR, Rifai N, Nordestgaard BG, Buring JE, Ridker PM. Lipoprotein(a) and risk of type 2 diabetes. Clin Chem 2010, 56:1252-1260. 10.1373/clinchem.2010.146779, 2912456, 20511445.
12. Boronat M, Varillas VF, Saavedra P, Suárez V, Bosch E, Carrillo A, Nóvoa FJ. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet Med 2006, 23:148-155.
13. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: Diagnosis and classification of Diabetes Mellitus 1999, 1-59. World Health Organization, Geneva, World Health Organization.
14. Matthews DR, Hosker JP, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
15. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees 1984, Wadsworth International, Belmont, CA.
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
17. Park MY, Hastie T. Penalized logistic regression for detecting gene interactions. Biostatistics 2008, 9:30-50.
18. Qi Q, Workalemahu T, Zhang C, Hu FB, Qi L. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes. Eur Heart J 2012, 33:325-334. 10.1093/eurheartj/ehr350, 21900290.
19. Inoue K, Nago N, Matsuo H, Goto T, Miyamoto T, Saegusa T, Ishikawa S, Kario K, Nakamura Y, Igarashi M. Serum insulin and lipoprotein(a) concentrations. Diabetes Care 1997, 20:1242-1247. 10.2337/diacare.20.8.1242, 9250447.
20. Dahlën G, Berg K. Confirmation of an influence of the inherited Lp(a) variation on serum insulin and glucose levels. Clin Genet 1979, 16:418-427.
21. Haffner SM, Karhapaa P, Rainwater DL, Mykkanen L, Aldrete G, Laakso M. Insulin sensitivity and Lp(a) concentrations in normoglycemic men. Diabetes Care 1995, 18:193-199. 10.2337/diacare.18.2.193, 7729297.
22. Rainwater DL, Haffner SM. Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. Arterioscler Thromb Vasc Biol 1998, 18:1335-1341. 10.1161/01.ATV.18.8.1335, 9714142.
23. Sharma S, Merchant J, Fleming SE. Lp(a)-cholesterol is associated with HDLcholesterol in overweight and obese African American children and is not an independent risk factor for CVD. Cardiovasc Diabetol 2012, 11:10-17. 10.1186/1475-2840-11-10, 3292927, 22283971.